A case report and literature review of primary resistant Hodgkin lymphoma: a response to anti-PD-1 after failure of autologous stem cell transplantation and brentuximab vedotin

Hodgkin lymphoma (HL) is a highly curable hematologic malignancy, and ~70% of cases can be cured with combination chemotherapy with or without radiation. However, patients with primary resistant disease have a cure rate of <30%. For such patients, high-dose chemotherapy followed by autologous ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Peipei, Wang, Fan, Guan, Chaoyang, Ouyang, Jian, Shao, Xiaoyan, Chen, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036553/
https://www.ncbi.nlm.nih.gov/pubmed/27703376
http://dx.doi.org/10.2147/OTT.S112472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036553/
https://www.ncbi.nlm.nih.gov/pubmed/27703376
http://dx.doi.org/10.2147/OTT.S112472

Ejemplares similares